Emergencies in Infectious Diseases

  • Carmen Esther GonzalezEmail author
  • Kalen Jacobson
  • Mary Markovich
Part of the MD Anderson Cancer Care Series book series (MDCCS)


A cancer patient who visits The University of Texas MD Anderson Cancer Center Emergency Center (EC) with symptoms such as fever, hypotension, and changes in mental status will undergo an evaluation for possible sepsis. This chapter covers infectious complications in cancer patients. In it we describe specific infectious processes that most commonly affect our patient population: pneumonia, neutropenic fever, sepsis, and surgical wound infections. Infections related to the presence of catheters in various parts of the body, including central venous catheters, may be frequently associated with certain micro-organisms.


Cancer Infection Immunocompromise Sepsis Pneumonia Neutropenia Catheter-associated infections Surgical wound infections 

Suggested Readings

  1. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.CrossRefGoogle Scholar
  2. Aujesky D, Fine MJ. The pneumonia severity index: a decade after initial derivation and validation. Clin Infect Dis. 2008;47:S133–9.CrossRefPubMedGoogle Scholar
  3. De Souza V, Serufo JC, da Costa Rocha MO, et al. Performance of a modified MASCC index score for identifying low-risk febrile neutropenic patients. Support Care Cancer. 2008;16:841–6.CrossRefGoogle Scholar
  4. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013;39:165–228.CrossRefPubMedGoogle Scholar
  5. Fowler Jr V, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695–703.CrossRefPubMedGoogle Scholar
  6. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427–31.CrossRefPubMedGoogle Scholar
  7. Gonzalez C, Johnson T, Rolston K, Merriman K, Warneke C, Evans S. Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center. Cancer Med. 2014;doi: 10.1002/cam4.240 [Epub ahead of print].Google Scholar
  8. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest. 2001;119:397S–404S.CrossRefPubMedGoogle Scholar
  9. Kern W. Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis. 2006;42:533–40.CrossRefPubMedGoogle Scholar
  10. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854–62.CrossRefPubMedGoogle Scholar
  11. Lahoti A, Kantarjian H, Salahudeen A, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116:4063–8.PubMedCentralCrossRefPubMedGoogle Scholar
  12. Mermel L, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.PubMedCentralCrossRefPubMedGoogle Scholar
  13. O’Grady N, Alexander M, Dellinger E, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep. 2002;51:1–29.PubMedGoogle Scholar
  14. O’Grady N, Barie P, Bartlett J, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American college of critical care medicine and the infectious diseases society of America. Crit Care Med. 2008;36:1330–49.CrossRefPubMedGoogle Scholar
  15. Pajman AD, Moss M, Mannino DM, et al. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129:1432–40.CrossRefGoogle Scholar
  16. Pene F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancy in the intensive care unit. Crit Care Med. 2008;36:690–6.CrossRefPubMedGoogle Scholar
  17. Rolston K. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;12:218–23.CrossRefGoogle Scholar
  18. Rolston KV. Management of Infections in the neutropenic patient. Annu Rev Med. 2004;55:519–26.CrossRefPubMedGoogle Scholar
  19. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228–33.CrossRefPubMedGoogle Scholar
  20. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Carmen Esther Gonzalez
    • 1
    Email author
  • Kalen Jacobson
    • 1
  • Mary Markovich
    • 1
  1. 1.Department of Emergency Medicine, Unit 1468The University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations